Yash’s Toxic Targets Massive ₹100 Crore Global Opening Based on Pre-Sale Velocity
Per IMDb's advance booking tracker, Yash's "Toxic" is tracking for a ₹100 crore-plus global opening day—a number built entirely on pre-sale inventory, not realised collections.

Advance booking measures intent; the ₹100 crore ceiling is the yield if every pre-booked seat converts and walk-ins layer on top.
What the Pre-Sale Signal Captures
The projection aggregates pre-sale numbers across domestic and overseas territory rights, with the India share typically anchoring the larger portion of the gross on Yash-led titles. The key variable isn't the pre-sale total itself—it's sell-through on release day. On a saturation release, the opening day gross depends on whether the pre-booked inventory clears at expected pricing and whether additional screens fill via day-of demand. Pre-sale velocity marks the ceiling; realised footfall sets the floor.
A Recent Comparable
Sacnilk's tracker provides a clean counterweight. "Vishwanath and Sons," the Suriya-starrer, grossed ₹22.10 crore in India over its second weekend and, per the source, became the first Indian title of 2026 to hit the $2.5 million North America milestone. Different star, different language, different release architecture—but a usable data point on what a committed theatrical title clears in steady-state. "Toxic's" projected opening, if it lands, effectively front-loads several comparable weekends into a single release window.
The Distribution Math
For a Yash-starrer, the opening day take feeds straight into exhibitor recovery and territory rights repricing. A ₹100 crore-plus opener resets the minimum guarantee benchmarks for the next comparable release. A miss against that bar shifts the trade conversation from revenue scale to cost discipline. The ROI hinges on whether the theatrical cut recovers its production-plus-marketing outlay within the early theatrical window—the standard hurdle for tentpoles in this category.
Projected Lifetime, Pending Data
Until the opening day collections are reported, the ₹100 crore projection stays in forecast territory. The realised gross will land somewhere between the pre-sale ceiling and the conservative trade estimates, and that delta will determine whether "Toxic" enters 2026 as a category-defining opener or a high-conviction performer that fell short of its own pre-release curve. Track the Day 1 worldwide net, the India net after taxes, and the overseas split by territory—those three numbers will write the verdict.